Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit

Fig. 1

Box plots of uncorrected biomarkers by disease stage and amyloid-β status as defined by Aβ42/Aβ40 ratio. Aβ40, amyloid-β1–40; Aβ42, amyloid-β1–42; AD, Alzheimer’s disease; CU, cognitively unimpaired; GFAP, glial fibrillary acidic protein; MCI, mild cognitive impairment; NfL, neurofilament light; pTau, phosphorylated tau; tTau, total tau; YKL40, chitinase-3-like protein-1

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193